Summary
Fibrinolytic therapy coupled with timely coronary angiography results in effective reperfusion in patients with ST-segment elevation myocardial infarction who cannot undergo primary percutaneous coronary intervention within 1 hour of presentation, according to the results of the Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction trial [STREAM; Armstrong PW et al. N Engl J Med 2013].
- Interventional Techniques & Devices
- Cardiology Clinical Trials
- Myocardial Infarction
- Cardiology & Cardiovascular Medicine
- Interventional Techniques & Devices
- Cardiology Clinical Trials
- Myocardial Infarction
- © 2013 MD Conference Express®